Emma Gårdmark

Emma Gårdmark is a Global Clinical Operations Program Director in Late Program Management at AstraZeneca, where they are accountable for the delivery of clinical programs to ensure quality, timeline, and cost effectiveness. With extensive experience in clinical study management, Emma previously held positions as Global Study Director and Global Study Associate Director, coordinating complex global studies and leading cross-functional teams. Emma's background includes a role as a Sales Representative in the pharmacy sector and project management within the healthcare field, showcasing a diverse skill set in clinical development and operations. They hold degrees in Molecular Biology from Lund University and Clinical Drug Development from Uppsala University, along with courses in human anatomy and physiology from Bond University.